Healthcare Equity
Invesco Global Health Care Innovation
Last updated: 2026-09-03
The Verdict
Invesco Global Health Care Innovation charges an expense ratio of 1.94%. On a $100,000 portfolio, that's $1,940 per year in fees, and it scales with the amount invested. Supreme.PM's decoded model tracked it at only 4% correlation over the measured period, so it should not be treated as a substitute for this fund, for a flat monthly subscription that does not change with portfolio size.
Expense Ratio
1.94%
Star Rating
2/ 5
Market Beta
1.02
Model Correlation
4%
Sharpe Ratio
0.29
Max Drawdown
27.58%
Supreme.PM Cost
Flat monthly subscription
Not a percentage of your assets
Performance
Performance comparison — 1Y: Fund 25.1% vs Model 20.3%; 3Y: Fund 37.6% vs Model 35.7%; 5Y: Fund 26.2% vs Model 26.6%.
Alpha After Fees
Supreme.PM's model shows 4% correlation with Invesco Global Health Care Innovation over the measured period. That is weak tracking: the model does not reproduce this fund's return pattern, and a negative figure means it moved in the opposite direction.
Fee Analysis
Invesco Global Health Care Innovation charges 1.94% of assets annually. Supreme.PM charges a flat monthly subscription instead, so its cost does not rise as a portfolio grows.
Data sources: Refinitiv Lipper, SEC EDGAR Filings, Supreme.PM Analytics
Past performance does not guarantee future results. Model returns are backtested and may not reflect actual trading conditions.
Related
Healthcare Equity Category
Browse all Healthcare Equity funds
Healthcare Equity Rankings
Top-rated Healthcare Equity funds
Our Methodology
How we decode fund strategies
T. Rowe Price Health Sciences Equity Fund
3-star rated
Schroder Global Healthcare
3-star rated
AXA Framlington Health
2-star rated
Pictet-Health
1-star rated
Polar Capital Healthcare Opportunities
4-star rated
Frequently Asked Questions
What is the expense ratio of Invesco Global Health Care Innovation?
Invesco Global Health Care Innovation has an expense ratio of 1.94%, charged as a percentage of the amount invested. Supreme.PM's decoded model is offered for a flat monthly subscription instead.
How does Supreme.PM replicate Invesco Global Health Care Innovation?
Supreme.PM builds a transparent, rules-based model of listed securities designed to track this fund's return profile. Over the measured period it tracked the fund poorly, at 4% correlation. The model is published in full, so its positions are visible rather than disclosed with a delay.
What are the risks of fund replication?
While our models aim for high correlation, they may not perfectly match the fund's returns due to timing differences in rebalancing, transaction costs, and disclosure delays. Backtested results may not reflect future performance.
Get This Strategy
Start investing with Supreme.PM's decoded model and save on fees while capturing similar returns.